|
Sign In to gain access to subscriptions and/or personal tools.
|
Lupus, Vol. 15, No. 12,
835-839 (2006)
DOI: 10.1177/0961203306073133
Mortality related to cerebrovascular disease in systemic lupus erythematosus
S Bernatsky
Division of Clinical Epidemiology Montreal General Hospital, Montreal, Canada
A Clarke
Division of Clinical Epidemiology Montreal General Hospital, Montreal, Canada, Division of Clinical Immunology/Allergy, Montreal General Hospital, Montreal, Canada
D D Gladman
Toronto Western Hospital, Toronto, ON, Canada
M Urowitz
Toronto Western Hospital, Toronto, ON, Canada
P R Fortin
Toronto Western Hospital, Toronto, ON, Canada
S G Barr
University of Calgary, Calgary, AB, Canada
J-L Senécal
Division of Rheumatology, University of Montreal School of Medicine, Hôpital Notre-Dame Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Canada
M Zummer
Hôpital Maisonneuve-Rosemont, CHUM, Montreal, PQ, Canada
S Edworthy
University of Calgary, Calgary, AB, Canada
J Sibley
Department of Rheumatology, Royal University Hospital, Saskatoon, SK, Canada
J Pope
St Joseph’s Hospital, University of Western Ontario, London, ON, Canada
S Ensworth
Division of Rheumatology, Mary Pack Arthritis Centre, University of British Columbia, Vancouver, BC, Canada
R Ramsey-Goldman
Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago IL, USA
J G Hanly
Division of Rheumatology, Department of Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada
The objective of this study was to examine mortality rates related to cerebrovascular disease in systemic lupus erythematosus (SLE) compared to the general population. Our sample was a multisite Canadian SLE cohort (10 centres, n = 2688 patients). Deaths due to cerebrovascular disease were ascertained by vital statistics registry linkage using ICD diagnostic codes. Standardized mortality ratio (SMR, ratio of deaths observed to expected) estimates were calculated. The total SMR for death due to cerebrovascular disease was 2.0 (95% confidence interval [CI] 1.0, 3.7). When considering specific types of events, the category with the greatest increased risk was that of ill-defined cerebrovascular events (SMR 44.9, 95% CI 9.3, 131.3) and other cerebrovascular disease (SMR 8.4, 95% CI 2.3, 21.6). Deaths due to cerebral infarctions appeared to be less common than hemorrhages and other types of cerebrovascular events. Our data suggest an increase in mortality related to cerebrovascular disease in SLE patients compared to the general population. The large increase in illdefined cerebrovascular events may represent cases of cerebral vasculitis or other rare forms of nervous system disease; alternately, it may reflect diagnostic uncertainty regarding the etiology of some clinical presentations in SLE patients. The suggestion that more deaths are attributed to cerebral hemorrhage, as opposed to infarction, indicates that inherent or iatrogenic factors (eg, thrombocytopenia or anticoagulation) may be important. In view of the paucity of large-scale studies of mortality attributed to neuropsychiatric outcomes in SLE, our findings highlight the need for additional research in large SLE cohorts.
Key Words: cerebrovascular disease • mortality • systemic lupus erythematosus
References
- Petri M. Epidemiology of systemic lupus erythematosus . Best Practice & Research Clinical Rheumatology 2002; 16: 847-858 .[Medline]
[Order article via Infotrieve]
- Hanly JG. Neuropsychiatric lupus . Rheum Dis Clin North Am 2005; 31: 273-298 .[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Hanly JG, Walsh NM, Sangalang V. Brain pathology in systemic lupus erythematosus . J Rheumatol 1992; 19: 732-741 .[ISI][Medline]
[Order article via Infotrieve]
- Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus . Medicine (Baltimore) 1968; 47: 337-369 .[Medline]
[Order article via Infotrieve]
- Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955-1977 . Semin Arthritis Rheum 1979; 8: 212-221 .[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Mody G, Parag K, Nathoo B, Pudifin D, Duursma J, Seedat Y. High mortality with systemic lupus erythematosus in hospitalized African blacks . Br J Rheumatol 1994; 33: 1151-1153 .[Abstract/Free Full Text]
- Samanta A, Feehally J, Roy S, Nichol F, Sheldon P, Walls J. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus . Ann Rheum Dis 1991; 50: 490-492 .[Abstract/Free Full Text]
- Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupuserythematosus-a prospective-study of patients from a defined population . Medicine 1989; 68: 141-150 .[Medline]
[Order article via Infotrieve]
- Isenberg D, Gladman D. The Systemic Lupus International Collaborating Clinics group-origins and outcomes . Lupus 2001; 10: 375-377 .[Free Full Text]
- Bernatsky S, Boivin J-F, Joseph Let al. An international cohort study of cancer in SLE . Arthritis Rheum 2005; 52: 1481-1490 .[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Hochberg M. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1998; 41: 751-751 .[ISI][Medline]
[Order article via Infotrieve]
- Tan E, Cohen AS, Fries J, Masi A, McShane D, Rothfield N. The 1982 revised criteria for the classification of SLE . Arthritis Rheum 1982; 25: 1271-1277 .[ISI][Medline]
[Order article via Infotrieve]
- Breslow ND. Statistical methods in cancer research. The design and analysis of cohort studies. WHO International Agency for Research on Cancer , 1987: 302-304.
- Bjornadal L, Yin L, Granath F, Klareskog L, Ekbom A. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95 . J Rheumatol 2004; 31: 713-719 .[ISI][Medline]
[Order article via Infotrieve]
- Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality . J Rheumatol 1995; 22: 1265-1270 .[ISI][Medline]
[Order article via Infotrieve]
- Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death . J Rheumatol 1995; 22: 1259-1264 .[ISI][Medline]
[Order article via Infotrieve]
- Rosner S, Ginzler EM, Diamond HSet al. A multicenter study of outcome in systemic lupus erythematosus . Arthritis Rheum 1982; 25: 612-617 .[ISI][Medline]
[Order article via Infotrieve]
- Stoll T, Seifert B, Isenberg D. SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus . Br J Rheumatol 1996; 35: 248-254 .[Abstract/Free Full Text]
- Jonsen A, Bengtsson AA, Nived O, Ryberg B, Sturfelt G. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality . Rheumatology 2002; 41: 1308-1312 .[Abstract/Free Full Text]
- Ward M. Education level and mortality in systemic lupus erythematosus (SLE): evidence of underascertainment of deaths due to SLE in ethnic minorities with low education levels . Arthritis Rheum 2004; 51: 616-624 .[CrossRef][ISI][Medline]
[Order article via Infotrieve]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
|
